Atrial fibrillation, or Afib, is the most common type of heart arrhythmia. Afib increases your risk of heart attack and ...
Medical Xpress on MSN6h
Clinical trial finds new gene editing therapy for heart condition to be safe and effectiveResults for the Phase I clinical trial, published in the New England Journal of Medicine, bring hope for people with ...
A recent discussion with BDO's clinical trials editor and Audrey Davis of CSC, discussed strategies to increase clinical ...
A patient with small cell lung cancer shared her clinical trial experience with CURE® and how she encourages other patients ...
The National Institutes of Health (NIH) has unveiled a new artificial intelligence (AI) algorithm designed to more ...
The bidirectional research examines both laboratory findings and human clinical trial data, revealing that the medicinal use ...
Does it work? Does it cause any side effects? For each clinical trial, study organizers must follow a plan, known as a protocol. A protocol describes exactly what happens during the study, and ...
An AI tool called Muse aims to optimize clinical trial patient recruitment and accelerate the development of new therapies.
A revolutionary breakthrough in cataract treatment is on the horizon, with the emergence of C-KAD, a new eye drop therapy.
Ocugen announces positive preliminary data from OCU410 Phase 1 clinical trial for geographic atrophy
Ocugen has announced positive Phase 1 trial results for OCU410, a one-time gene therapy for geographic atrophy secondary to ...
Researchers from the National Institutes of Health (NIH) have developed an artificial intelligence (AI) algorithm to help ...
Neurogene (NGNE) announced an update on its ongoing Phase 1/2 open-label clinical trial evaluating NGN-401 gene therapy for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback